Therefore in this study, MRI was able to identify that Hexarelin represents a promising candidate for pharmacological protection of cardiac function after a cardiac ischaemic event. The modulation of both fibrotic and inflammatory pathways in heart muscle raise hopes that hexarelin could provide a complete cardioprotective treatment.
References
1. Hausenloy DJ and Yellon DM. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J. Clin. Invest. 2013;123:92–100.
2. Segura AM, et al. Fibrosis and heart failure. Heart Fail. Rev 2014;19:173–185.
3. Potz BA, et al. Extracellular Vesicle Injection Improves Myocardial Function and Increases Angiogenesis in a Swine Model of Chronic Ischemia. J Am Heart Assoc. 2018;7(12): e008344. Available at jaha.ahajournals.org/content/7/12/e008344.
4. Isgaard J et al. Cardiovascular effects of ghrelin and growth hormone secretagogues. Cardiovasc Hematol Disord Drug Targets 2008;8(2):133–137.
5. Kishimoto, I., et al. Therapeutic potential of ghrelin in cardiac diseases. Expert Rev. Endocrinol. Metab. 2009;4:283–289.
6. Ma Y, et al. Growth hormone secretagogues protect mouse cardiomyocytes from in vitro ischemia/reperfusion injury through regulation of intracellular calcium. PLoS One. 2012;7(4):e35265. doi: 10.1371/journal.pone.0035265. Available at www.ncbi.nlm.nih.gov/pmc/articles/PMC3320867/pdf/pone.0035265.pdf
7. Granata R, et al. Cardiovascular actions of the ghrelin gene-derived peptides and growth hormone-releasing hormone. Exp Biol Med (Maywood). 2011;236(5):505–514.
8. Angelino E, et al. Antifibrotic activity of acylated and unacylated ghrelin. Int. J. Endocrinol. 2015:385682.
9. Mao Y, et al. Hexarelin treatment in male ghrelin knockout mice after myocardial infarction. Endocrinology 2013;154:3847–3854.
10. Mao Y, et al The cardiovascular action of hexarelin. J. Geriatr. Cardiol. 2014;11:253–258.
11. Broglio F, et al. Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery. Eur J Pharmacol. 2002 Jul 19;448(2-3):193–200.
12. McDonald H, et al. Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarction. Physiol Rep 2018;6(9). Epub ahead of print. Available at doi.org/10.14814/phy2.13699.